We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
Cap. Flow
-$4.5B
Cap. Flow %
-4.19%
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 11.39%
3 Healthcare 9.26%
4 Consumer Discretionary 6.73%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFC
3001
DELISTED
Premier Financial Corp. Common Stock
PFC
$796K ﹤0.01%
27,776
+2,194
+9% +$60.3K
INOV
3002
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$796K ﹤0.01%
75,174
-11,023
-13% -$138K
DVN icon
3003
PUT
Devon Energy
DVN
$51.4B
$795K ﹤0.01%
25,000
-37,100
-60% -$1.36M
APEI icon
3004
American Public Education
APEI
$975M
$793K ﹤0.01%
18,441
+1,596
+9% +$49K
IPHI
3005
DELISTED
INPHI CORPORATION
IPHI
$793K ﹤0.01%
26,348
-1,675
-6% -$52.1K
FET icon
3006
Forum Energy Technologies
FET
$795M
$792K ﹤0.01%
3,601
+609
+20% +$170K
EBF icon
3007
Ennis
EBF
$558M
$790K ﹤0.01%
40,126
+4,364
+12% +$88.3K
KGC icon
3008
CALL
Kinross Gold
KGC
$27.8B
$790K ﹤0.01%
+200,000
New +$798K
NVEE
3009
DELISTED
NV5 Global
NVEE
$790K ﹤0.01%
56,740
+11,320
+25% +$140K
VNDA icon
3010
Vanda Pharmaceuticals
VNDA
$315M
$788K ﹤0.01%
46,758
+5,431
+13% +$90.9K
RVNC
3011
DELISTED
Revance Therapeutics, Inc.
RVNC
$788K ﹤0.01%
25,575
-2,491
-9% -$80.1K
ANIK icon
3012
Anika Therapeutics
ANIK
$277M
$783K ﹤0.01%
15,765
+3,321
+27% +$188K
GABC icon
3013
German American Bancorp
GABC
$1.92B
$783K ﹤0.01%
23,468
+4,118
+21% +$143K
HBNC icon
3014
Horizon Bancorp
HBNC
$1.06B
$780K ﹤0.01%
39,020
+3,138
+9% +$61.2K
CMO
3015
DELISTED
Capstead Mortgage Corp.
CMO
$780K ﹤0.01%
90,130
-4,382
-5% -$37.9K
GKOS icon
3016
Glaukos
GKOS
$10.1B
$778K ﹤0.01%
25,246
-151
-0.6% -$4.57K
AGX icon
3017
Argan
AGX
$8.31B
$777K ﹤0.01%
18,095
-2,566
-12% -$108K
MTGE
3018
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$777K ﹤0.01%
43,469
+1,787
+4% +$31.6K
BKE icon
3019
Buckle
BKE
$2.37B
$776K ﹤0.01%
35,044
-13,951
-28% -$293K
DHIL
3020
DELISTED
Diamond Hill
DHIL
$776K ﹤0.01%
3,755
+429
+13% +$89.4K
LL
3021
DELISTED
LL Flooring Holdings, Inc.
LL
$775K ﹤0.01%
32,371
-20,588
-39% -$545K
OSG
3022
Octave Specialty Group
OSG
$255M
$770K ﹤0.01%
49,139
+9,573
+24% +$148K
CHEF icon
3023
Chefs' Warehouse
CHEF
$4.54B
$770K ﹤0.01%
33,451
+6,160
+23% +$133K
GTE icon
3024
Gran Tierra Energy
GTE
$246M
$770K ﹤0.01%
27,614
-195
-0.7% -$5.29K
HAYN
3025
DELISTED
Haynes International, Inc.
HAYN
$769K ﹤0.01%
20,725
+2,370
+13% +$92.7K

Similar funds

Credit Suisse's Q1 2018 Portfolio in Review

As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.

  • Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
  • Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
  • Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
  • Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
  • Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
  • Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
  • Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.